Cost-Effectiveness of Secukinumab Compared with Ustekinumab And Etanercept for the Treatment Of Moderate-to-Severe Plaque Psoriasis in Greece
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.1286
https://www.valueinhealthjournal.com/article/S1098-3015(16)32652-3/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1209
First Page :
A569
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32652-3&doi=10.1016/j.jval.2016.09.1286